ZCM
ATRC icon

Zebra Capital Management’s AtriCure ATRC Stock Holding History

Zebra Capital Management’s Portfolio ATRC Stock Details ATRC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-10,778
Closed -$322K – 253
2019
Q2 		$322K Buy
+10,778
New +$315K 0.17% 238

Other funds holding ATRC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
TA
Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return

Zebra Capital Management's ATRC Position: Q3 2019 in Review

Zebra Capital Management sold out of AtriCure (ATRC) in Q3 2019, closing a stake of 10,778 shares — an estimated $322K sold.

Zebra Capital Management first reported a position in ATRC in Q2 2019 and held it in 1 quarter. The position peaked at $322K in Q2 2019. 141 funds tracked by Wall St. Rank hold ATRC as of Q3 2019.

  • Zebra Capital Management reported no remaining AtriCure position as of Q3 2019 after selling out during the quarter.
  • Zebra Capital Management sold 10,778 AtriCure shares in Q3 2019, an estimated $322K.
  • Zebra Capital Management first reported a position in AtriCure in Q2 2019 and held it in 1 quarter.
  • Zebra Capital Management's AtriCure position peaked at $322K in Q2 2019.
  • 141 funds tracked by Wall St. Rank held AtriCure as of Q3 2019.

Based on Zebra Capital Management's 13F filing for Q3 2019, filed 14 Nov 2019.